Venture Life Group PLC (LON:VLG)‘s stock had its “speculative buy” rating restated by stock analysts at Beaufort Securities in a report released on Thursday.
Separately, Panmure Gordon reiterated a “buy” rating and set a GBX 128 ($1.67) price objective on shares of Venture Life Group PLC in a report on Wednesday, September 21st.
Venture Life Group PLC (LON:VLG) opened at 55.00 on Thursday. Venture Life Group PLC has a 12 month low of GBX 43.00 and a 12 month high of GBX 81.92. The firm’s market cap is GBX 19.75 million. The firm’s 50 day moving average is GBX 51.62 and its 200-day moving average is GBX 56.39.
Venture Life Group PLC Company Profile
Venture Life Group PLC is a United Kingdom-based consumer self-care company. The Company focuses on developing, manufacturing and commercializing products for the ageing population. Its product range includes medical devices (such as those for minor aches and pains, and alleviating symptoms associated with hemorrhoids and itchy skin), food supplements (such as those for lowering cholesterol and improving brain function), and dermo-cosmetics and cosmetics for addressing the signs of skin-ageing.
Receive News & Ratings for Venture Life Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.